Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set

Authors
Publication date
13 January 2021
Publisher
TAYLOR & FRANCIS LTD

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    UCL Discovery

    redirect
    oaioai:eprints.ucl.ac.uk.OAI2:101...
    Last time updated on 17/03/2023